Illumina Inc (ILMN)
Healthcare
Diagnostics & Research
205.10 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Illumina Inc (ILMN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 6,650 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10,122 | 10,111 | 10,040 | 6,081 | 6,014 | 6,303 | 6,182 | 6,087 | 6,177 | 6,644 | 6,559 | 6,650 | |
| 2,506 | 2,609 | 2,583 | 2,459 | 2,373 | 2,746 | 2,673 | 2,641 | 2,796 | 3,289 | 2,738 | 2,834 | |
| 927 | 1,048 | 1,108 | 920 | 869 | 1,127 | 1,113 | 934 | 1,050 | 1,418 | 1,089 | 1,040 | |
| 933 | 1,054 | 1,115 | 994 | 939 | 1,220 | 1,237 | 1,155 | 1,278 | 1,633 | 1,155 | 1,168 | |
| 709 | 752 | 650 | 657 | 715 | 751 | 714 | 716 | 751 | 854 | 738 | 764 | |
| 615 | 587 | 584 | 561 | 574 | 547 | 537 | 575 | 590 | 564 | 611 | 629 | |
| 1,621 | – | – | – | 1,285 | 1,234 | 1,192 | 1,161 | 1,130 | 1,129 | – | – | |
| 2,527 | 2,545 | 2,545 | 1,079 | 1,113 | 1,113 | 1,113 | 1,113 | 1,113 | 1,113 | 1,284 | 1,284 | |
| 3,029 | 2,993 | 2,940 | 278 | 305 | 295 | 278 | 238 | 225 | 210 | 430 | 410 | |
| 4,224 | 4,366 | 4,306 | 4,645 | 3,889 | 3,930 | 3,814 | 3,829 | 3,796 | 3,921 | 3,883 | 3,812 | |
| 1,482 | 1,570 | 1,474 | 2,208 | 975 | 1,547 | 1,440 | 1,461 | 1,962 | 1,585 | 1,566 | 1,578 | |
| 85 | 86 | 86 | 815 | 73 | 578 | 577 | 578 | 1,076 | 577 | 579 | 500 | |
| 240 | 245 | 201 | 199 | 191 | 221 | 207 | 200 | 218 | 240 | 218 | 230 | |
| 1,489 | 1,489 | 1,490 | 1,490 | 1,988 | 1,490 | 1,491 | 1,492 | 994 | 1,490 | 1,490 | – | |
| 5,898 | 5,745 | 5,734 | 1,436 | 2,125 | 2,373 | 2,368 | 2,258 | 2,381 | 2,723 | 2,676 | 2,838 | |
| 157 | -19 | -145 | -2,133 | -1,428 | -1,242 | -1,111 | -876 | -726 | -392 | -258 | -51 | |
| 158 | 159 | 159 | 159 | 160 | 160 | 159 | 157 | 154 | 154 | 154 | 153 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.